CELEX: 62019TB0549
Language: en
Date: 2019-09-26 00:00:00
Title: Case T-549/19 R: Order of the President of the General Court of 26 September 2019 — Medac Gesellschaft für klinische Spezialpräparate v Commission (Application for interim measures — Orphan medicinal product — Application to suspend operation of a measure — No urgency)

20.1.2020   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 19/53
            
         
      Order of the President of the General Court of 26 September 2019 — Medac Gesellschaft für klinische Spezialpräparate v Commission
      (Case T-549/19 R)
      (Application for interim measures - Orphan medicinal product - Application to suspend operation of a measure - No urgency)
      (2020/C 19/64)
      Language of the case: German
      
         Parties
      
      
         Applicant: Medac Gesellschaft für klinische Spezialpräparate mbH (Wedel, Germany) (represented by: P. von Czettritz, lawyer)
      
         Defendant: European Commission (represented by: J. F. Brakeland, L. Haasbeek and C. Hermes, acting as Agents)
      
         Re:
      
      Application under Articles 278 and 279 TFEU to suspend the operation of Article 5 of Commission Implementing Decision C (2019) 4858 final of 20 June 2019 granting marketing authorisation under Regulation No 726/2004 of the European Parliament and of the Council for ‘Trecondi-treosulfan’, a medicinal product for human use.
      
         Operative part of the order
      
      The Court orders:
      
                  1.
               
               
                  
                     The application for interim measures is refused.
                  
               
            
                  2.
               
               
                  
                     Costs are reserved.